Herbal Medicine By China’s Tasly First TCM In Western Trials
This article was originally published in PharmAsia News
Executive Summary
Traditional Chinese medicine appears to be gaining greater acceptance in the Western, although there is widespread agreement on a need for standardization. China's Tasly Pharmaceutical has submitted an herbal drug, danshen, already available in much of Africa for treating a variety of diseases, is undergoing clinical trials in the European Union and in the United States where the FDA approved it as the first TCM for testing. The lack of scientific proof for the effectiveness of herbal treatments, some used in other countries for hundreds of years, has stymied their acceptance by Western drug makers and nations. U.S. and Chinese agree globalization will come only after TCM compounds are subjected to standardization. (Click here for more